T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Group 1 Automotive
GPI
$3.14B
| $1.12M | ﹤0.01% |
12,500
| – | – |
|
|
CIM
1677
Chimera Investment
CIM
$993M
| $1.12M | ﹤0.01% |
23,460
-2,067
| -8% | -$99.9K |
|
|
HTD
1678
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$904M
| $1.11M | ﹤0.01% |
50,000
| – | – |
|
1679
Cullen/Frost Bankers
CFR
$10.5B
| $1.11M | ﹤0.01% |
15,750
-500
| -3% | -$37.7K |
|
1680
Portland General Electric
POR
$5.92B
| $1.11M | ﹤0.01% |
29,400
| – | – |
|
|
UIL
1681
DELISTED
UIL HOLDINGS
UIL
| $1.11M | ﹤0.01% |
25,499
+300
| +1% | +$12.2K |
|
1682
Allison Transmission
ALSN
$10.2B
| $1.11M | ﹤0.01% |
32,700
| – | – |
|
1683
ITT
ITT
$19.4B
| $1.11M | ﹤0.01% |
27,400
-9,000
| -25% | -$376K |
|
1684
Thor Industries
THO
$4.11B
| $1.11M | ﹤0.01% |
19,800
-3,900
| -16% | -$210K |
|
|
EGN
1685
DELISTED
Energen
EGN
| $1.1M | ﹤0.01% |
17,318
-3,376
| -16% | -$214K |
|
1686
Hawaiian Electric Industries
HE
$2.04B
| $1.1M | ﹤0.01% |
32,900
+2,800
| +9% | +$81.5K |
|
1687
Tanger
SKT
$4.42B
| $1.1M | ﹤0.01% |
29,780
+2,200
| +8% | +$78.6K |
|
1688
Cinemark Holdings
CNK
$4.37B
| $1.1M | ﹤0.01% |
30,851
+3,551
| +13% | +$123K |
|
|
GPOR
1689
DELISTED
Gulfport Energy Corp.
GPOR
| $1.09M | ﹤0.01% |
26,233
+238
| +0.9% | +$11.1K |
|
1690
Herbalife
HLF
$1.28B
| $1.09M | ﹤0.01% |
57,600
| – | – |
|
|
CTB
1691
DELISTED
Cooper Tire & Rubber Co.
CTB
| $1.08M | ﹤0.01% |
31,100
| – | – |
|
1692
World Kinect Corp
WKC
$1.9B
| $1.07M | ﹤0.01% |
22,900
-2,000
| -8% | -$86.5K |
|
|
DBD
1693
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.07M | ﹤0.01% |
30,990
+2,800
| +10% | +$98.7K |
|
|
RDC
1694
DELISTED
Rowan Companies Plc
RDC
| $1.07M | ﹤0.01% |
46,000
+4,900
| +12% | +$113K |
|
1695
Avista
AVA
$3.24B
| $1.07M | ﹤0.01% |
30,290
| – | – |
|
1696
Hyatt Hotels
H
$16.9B
| $1.06M | ﹤0.01% |
17,600
-1,200
| -6% | -$70.4K |
|
1697
Liberty Broadband Class C
LBRDK
$5.29B
| $1.06M | ﹤0.01% |
+21,275
| New | +$1.05M |
|
1698
MSC Industrial Direct
MSM
$6.77B
| $1.06M | ﹤0.01% |
13,000
+500
| +4% | +$40.7K |
|
1699
Darling Ingredients
DAR
$10.4B
| $1.05M | ﹤0.01% |
58,000
| – | – |
|
|
BMR
1700
DELISTED
BIOMED REALTY TRUST INC
BMR
| $1.04M | ﹤0.01% |
48,400
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.